Glucotrack Completes Bridge Financing To Support Its Growth Plans
Glucotrack, Inc. (NASDAQ:GCTK) ("Glucotrack" or the "Company"), together with its operating business Lōkahi Therapeutics™ ("Lōkahi"), a clinical-stage biopharmaceutical company advancing
Glucotrack raised money through bridge financing—a short-term loan that helps companies keep going while they work on their plans. When a company does this, it shows they need cash right now, so watch to see if their actual business progress matches their growth goals.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.